Literature DB >> 11600888

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

H A Arnett1, J Mason, M Marino, K Suzuki, G K Matsushima, J P Ting.   

Abstract

Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600888     DOI: 10.1038/nn738

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  344 in total

1.  Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.

Authors:  Jee Y Lee; So R Kang; Tae Y Yune
Journal:  J Neurotrauma       Date:  2015-03-06       Impact factor: 5.269

Review 2.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

3.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination.

Authors:  Jigisha R Patel; Erin E McCandless; Denise Dorsey; Robyn S Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

4.  Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.

Authors:  S J Crocker; R Bajpai; C S Moore; R F Frausto; G D Brown; R R Pagarigan; J L Whitton; A V Terskikh
Journal:  Neuropathol Appl Neurobiol       Date:  2011-10       Impact factor: 8.090

Review 5.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

6.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

7.  ATP-P2X7 receptor signaling controls basal and TNFα-stimulated glial cell proliferation.

Authors:  Jian Zou; Ryan P Vetreno; Fulton T Crews
Journal:  Glia       Date:  2012-02-01       Impact factor: 7.452

8.  3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.

Authors:  Isabella Russo; Luca Caracciolo; David Tweedie; Sang-Ho Choi; Nigel H Greig; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-07-25       Impact factor: 5.372

9.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.